Comparison of the effect of Evening primrose oil with Misoprostol on cervical ripening before hysteroscopy in women without a previous vaginal delivery.

Phase 3

Recruiting

Conditions: eiomyoma of uterus.
Leiomyoma of uterus

Registration Number: IRCT20220930056059N2

Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 100

Inclusion Criteria

Women candidates for hysteroscopy
Candidate for hysteroscopy Aged 25-75 years
non-pregnant
The patient consent to participate in the study
Who have no history of natural childbirth or cervical manipulation

Exclusion Criteria

Those who had a contraindication to PGs (history of severe asthma, glaucoma, preexisting cardiac disease, hypertension, or renal failure, bleeding disorders or consuming medications that inhibit blood clotting
Patients with a history of schizophrenia who take phenothiazines
patients with epilepsy and seizure
Significant uterovaginal prolapse precluding the administration of vaginal tablets

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Size of first input hegar dilator. Timepoint: At the beginning of the study and immediately after the hysteroscopy (4-6 hours after taking the drug). Method of measurement: Measurement of cervical dilatation: Hegar dilator.

Secondary Outcome Measures

Name	Time	Method
Complications of the drug before, during and after hysteroscopy. Timepoint: After prescribing the drug (4-6 hours later) and immediately before the hysteroscopic surgery and during the operation. Method of measurement: Clinical observation.;Cervical consistency after drug administration. Timepoint: After prescribing the drug (4-6 hours later) and immediately before the hysteroscopic surgery and during the operation. Method of measurement: Check the consistency of the cervix with a finger examination, Hegar Dilator.;Duration of cervical dilatation. Timepoint: After prescribing the drug (4-6 hours later) and immediately before the hysteroscopic surgery and during the operation. Method of measurement: Timing.;The total duration of surgery. Timepoint: During the operation. Method of measurement: Timing.